|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu S, Zheng R, Zhang M, Zhang S, Sun X
and Chen W: Incidence and mortality of colorectal cancer in China,
2011. Chin J Cancer Res. 27:22–28. 2015.PubMed/NCBI
|
|
4
|
Yan Y, Shen Z, Ye Y, Jiang K, Zhang H,
Shen C, Mustonen H, Puolakkainen P and Wang S: A novel molecular
marker of prognosis in colorectal cancer: Vasohibin-1. Med Oncol.
31:8162014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kornienko AE, Guenzl PM, Barlow DP and
Pauler FM: Gene regulation by the act of long non-coding RNA
transcription. BMC Biol. 11:592013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tsai MC, Manor O, Wan Y, Mosammaparast N,
Wang JK, Lan F, Shi Y, Segal E and Chang HY: Long noncoding RNA as
modular scaffold of histone modification complexes. Science.
329:689–693. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guttman M, Donaghey J, Carey BW, Garber M,
Grenier JK, Munson G, Young G, Lucas AB, Ach R, Bruhn L, et al:
lincRNAs act in the circuitry controlling pluripotency and
differentiation. Nature. 477:295–300. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Franklin JL, Rankin CR, Levy S, Snoddy JR,
Zhang B, Washington MK, Thomson JM, Whitehead RH and Coffey RJ:
Malignant transformation of colonic epithelial cells by a
colon-derived long noncoding RNA. Biochem Biophys Res Commun.
440:99–104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Jatkoe T, Zhang Y, Mutch MG,
Talantov D, Jiang J, McLeod HL and Atkins D: Gene expression
profiles and molecular markers to predict recurrence of Dukes' B
colon cancer. J Clin Oncol. 22:1564–1571. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu MX, Chen X, Chen G, Cui QH and Yan GY:
A computational framework to infer human disease-associated long
noncoding RNAs. PLoS One. 9:e844082014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu Y, Zhang L, Wang Y, Li H, Ren X, Wei F,
Yu W, Wang X, Zhang L, Yu J and Hao X: Long noncoding RNA HOTAIR
involvement in cancer. Tumour Biol. 35:9531–9538. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chau YM, Pando S and Taylor HS: HOXA11
silencing and endogenous HOXA11 antisense ribonucleic acid in the
uterine endometrium. J Clin Endocrinol Metab. 87:2674–2680. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Richards EJ, Permuth-Wey J, Li Y, Chen YA,
Coppola D, Reid BM, Lin HY, Teer JK, Berchuck A, Birrer MJ, et al:
A functional variant in HOXA11-AS, a novel long non-coding RNA,
inhibits the oncogenic phenotype of epithelial ovarian cancer.
Oncotarget. 6:34745–34757. 2015.PubMed/NCBI
|
|
17
|
Potter SS and Branford WW: Evolutionary
conservation and tissue-specific processing of Hoxa 11 antisense
transcripts. Mamm Genome. 9:799–806. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yu H, Lindsay J, Feng ZP, Frankenberg S,
Hu Y, Carone D, Shaw G, Pask AJ, O'Neill R, Papenfuss AT and
Renfree MB: Evolution of coding and non-coding genes in HOX
clusters of a marsupial. BMC Genomics. 13:2512012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang J, Lv J and Liu Z: Identification of
stage-specific biomarkers in lung adenocarcinoma based on RNA-seq
data. Tumour Biol. 36:6391–6399. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo H, Zhao X, Wan X, Huang S and Wu D:
Gene microarray analysis of the lncRNA expression profile in human
urothelial carcinoma of the bladder. Int J Clin Exp Med.
7:1244–1254. 2014.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Svoboda M, Slyskova J, Schneiderova M,
Makovicky P, Bielik L, Levy M, Lipska L, Hemmelova B, Kala Z,
Protivankova M, et al: HOTAIR long non-coding RNA is a negative
prognostic factor not only in primary tumors, but also in the blood
of colorectal cancer patients. Carcinogenesis. 35:1510–1515. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yin DD, Liu ZJ, Zhang E, Kong R, Zhang ZH
and Guo RH: Decreased expression of long noncoding RNA MEG3 affects
cell proliferation and predicts a poor prognosis in patients with
colorectal cancer. Tumour Biol. 36:4851–4859. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang MH, Hu ZY, Xu C, Xie LY, Wang XY,
Chen SY and Li ZG: MALAT1 promotes colorectal cancer cell
proliferation/migration/invasion via PRKA kinase anchor protein 9.
Biochim Biophys Acta. 1852:166–174. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma H, Hao Y, Dong X, Gong Q, Chen J, Zhang
J and Tian W: Molecular mechanisms and function prediction of long
noncoding RNA. ScientificWorldJournal. 2012:5417862012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Matei D, Fang F, Shen C, Schilder J,
Arnold A, Zeng Y, Berry WA, Huang T and Nephew KP: Epigenetic
resensitization to platinum in ovarian cancer. Cancer Res.
72:2197–2205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ye Z, Zhou M, Tian B, Wu B and Li J:
Expression of lncRNA-CCAT1, E-cadherin and N-cadherin in colorectal
cancer and its clinical significance. Int J Clin Exp Med.
8:3707–3715. 2015.PubMed/NCBI
|
|
29
|
Shi D, Zheng H, Zhuo C, Peng J, Li D, Xu
Y, Li X, Cai G and Cai S: Low expression of novel lncRNA
RP11-462C24.1 suggests a biomarker of poor prognosis in colorectal
cancer. Med Oncol. 31:312014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qi P, Xu MD, Ni SJ, Huang D, Wei P, Tan C,
Zhou XY and Du X: Low expression of LOC285194 is associated with
poor prognosis in colorectal cancer. J Transl Med. 11:1222013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang EB, Yin DD, Sun M, Kong R, Liu XH,
You LH, Han L, Xia R, Wang KM, Yang JS, et al: P53-regulated long
non-coding RNA TUG1 affects cell proliferation in human non-small
cell lung cancer, partly through epigenetically regulating HOXB7
expression. Cell Death Dis. 5:e12432014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang MD, Chen WM, Qi FZ, Sun M, Xu TP, Ma
P and Shu YQ: Long non-coding RNA TUG1 is up-regulated in
hepatocellular carcinoma and promotes cell growth and apoptosis by
epigenetically silencing of KLF2. Mol Cancer. 14:1652015.
View Article : Google Scholar : PubMed/NCBI
|
